Replicative adenoviruses for cancer therapy View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2000-07

AUTHORS

Ramon Alemany, Cristina Balagué, David T. Curiel

ABSTRACT

Rapid advances are being made in the engineering of replication-competent viruses to treat cancer. Adenovirus is a mildly pathogenic human virus that propagates prolifically in epithelial cells, the origin of most human cancers. While virologists have revealed many details about its molecular interactions with the cell, applied scientists have developed powerful technologies to genetically modify or regulate every viral protein. In tandem, the limited success of nonreplicative adenoviral vectors in cancer gene therapy has brought the old concept of adenovirus oncolysis back into the spotlight. Major efforts have been directed toward achieving selective replication by the deletion of viral functions dispensable in tumor cells or by the regulation of viral genes with tumor-specific promoters. However, the predicted replication selectivity has not been realized because of incomplete knowledge of the complex virus–cell interactions and the leakiness of cellular promoters in the viral genome. Capsid modifications are being developed to achieve tumor targeting and enhance infectivity. Cellular and viral functions that confer greater oncolytic potency are also being elucidated. Ultimately, the interplay of the virus with the immune system will likely dictate the success of this approach as a cancer therapy. More... »

PAGES

723-727

Journal

TITLE

Nature Biotechnology

ISSUE

7

VOLUME

18

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/77283

DOI

http://dx.doi.org/10.1038/77283

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1020669485

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/10888838


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/06", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Biological Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/10", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Technology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0601", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Biochemistry and Cell Biology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1004", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical Biotechnology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adenoviridae", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Genetic Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Genetic Vectors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Models, Biological", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasms", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Division of Human Gene Therapy, Departments of Medicine, Pathology, and Surgery, Gene Therapy Center, University of Alabama at Birmingham, AL 35294-3300, Birmingham", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Division of Human Gene Therapy, Departments of Medicine, Pathology, and Surgery, Gene Therapy Center, University of Alabama at Birmingham, AL 35294-3300, Birmingham"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Alemany", 
        "givenName": "Ramon", 
        "id": "sg:person.01210770006.56", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01210770006.56"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Human Gene Therapy, Departments of Medicine, Pathology, and Surgery, Gene Therapy Center, University of Alabama at Birmingham, AL 35294-3300, Birmingham", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Division of Human Gene Therapy, Departments of Medicine, Pathology, and Surgery, Gene Therapy Center, University of Alabama at Birmingham, AL 35294-3300, Birmingham"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Balagu\u00e9", 
        "givenName": "Cristina", 
        "id": "sg:person.0676575104.48", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0676575104.48"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Human Gene Therapy, Departments of Medicine, Pathology, and Surgery, Gene Therapy Center, University of Alabama at Birmingham, AL 35294-3300, Birmingham", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Division of Human Gene Therapy, Departments of Medicine, Pathology, and Surgery, Gene Therapy Center, University of Alabama at Birmingham, AL 35294-3300, Birmingham"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Curiel", 
        "givenName": "David T.", 
        "id": "sg:person.014245610777.23", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014245610777.23"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/sj.cgt.7700104", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027092476", 
          "https://doi.org/10.1038/sj.cgt.7700104"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.gt.3300910", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047885588", 
          "https://doi.org/10.1038/sj.gt.3300910"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.onc.1203251", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008238922", 
          "https://doi.org/10.1038/sj.onc.1203251"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.cgt.7700001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030233705", 
          "https://doi.org/10.1038/sj.cgt.7700001"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.gt.3300585", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031256245", 
          "https://doi.org/10.1038/sj.gt.3300585"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nm0995-890", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002841399", 
          "https://doi.org/10.1038/nm0995-890"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nm0697-639", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021949192", 
          "https://doi.org/10.1038/nm0697-639"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/978-3-642-79496-4_8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005567172", 
          "https://doi.org/10.1007/978-3-642-79496-4_8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/11320", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023937493", 
          "https://doi.org/10.1038/11320"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/2057", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046761704", 
          "https://doi.org/10.1038/2057"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2000-07", 
    "datePublishedReg": "2000-07-01", 
    "description": "Rapid advances are being made in the engineering of replication-competent viruses to treat cancer. Adenovirus is a mildly pathogenic human virus that propagates prolifically in epithelial cells, the origin of most human cancers. While virologists have revealed many details about its molecular interactions with the cell, applied scientists have developed powerful technologies to genetically modify or regulate every viral protein. In tandem, the limited success of nonreplicative adenoviral vectors in cancer gene therapy has brought the old concept of adenovirus oncolysis back into the spotlight. Major efforts have been directed toward achieving selective replication by the deletion of viral functions dispensable in tumor cells or by the regulation of viral genes with tumor-specific promoters. However, the predicted replication selectivity has not been realized because of incomplete knowledge of the complex virus\u2013cell interactions and the leakiness of cellular promoters in the viral genome. Capsid modifications are being developed to achieve tumor targeting and enhance infectivity. Cellular and viral functions that confer greater oncolytic potency are also being elucidated. Ultimately, the interplay of the virus with the immune system will likely dictate the success of this approach as a cancer therapy.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/77283", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.7145216", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2474544", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1115214", 
        "issn": [
          "1087-0156", 
          "1546-1696"
        ], 
        "name": "Nature Biotechnology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "7", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "18"
      }
    ], 
    "keywords": [
      "viral functions", 
      "most human cancers", 
      "pathogenic human viruses", 
      "cellular promoters", 
      "viral genes", 
      "virus-cell interactions", 
      "viral genome", 
      "viral proteins", 
      "human cancers", 
      "cancer therapy", 
      "tumor-specific promoters", 
      "epithelial cells", 
      "molecular interactions", 
      "promoter", 
      "complex virus-cell interactions", 
      "human viruses", 
      "powerful technology", 
      "cancer gene therapy", 
      "selective replication", 
      "cells", 
      "replication selectivity", 
      "replication-competent virus", 
      "genome", 
      "rapid advances", 
      "tumor cells", 
      "virus", 
      "immune system", 
      "genes", 
      "gene therapy", 
      "protein", 
      "deletion", 
      "adenoviral vector", 
      "adenovirus", 
      "regulation", 
      "replication", 
      "virologists", 
      "targeting", 
      "interaction", 
      "limited success", 
      "incomplete knowledge", 
      "oncolytic potency", 
      "function", 
      "leakiness", 
      "applied scientists", 
      "major effort", 
      "infectivity", 
      "capsid modification", 
      "tandem", 
      "cancer", 
      "interplay", 
      "vector", 
      "origin", 
      "modification", 
      "oncolysis", 
      "advances", 
      "success", 
      "old concept", 
      "replicative adenovirus", 
      "potency", 
      "engineering", 
      "knowledge", 
      "scientists", 
      "efforts", 
      "spotlight", 
      "selectivity", 
      "system", 
      "detail", 
      "approach", 
      "therapy", 
      "technology", 
      "tumor targeting", 
      "concept", 
      "nonreplicative adenoviral vectors", 
      "adenovirus oncolysis", 
      "greater oncolytic potency"
    ], 
    "name": "Replicative adenoviruses for cancer therapy", 
    "pagination": "723-727", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1020669485"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/77283"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "10888838"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/77283", 
      "https://app.dimensions.ai/details/publication/pub.1020669485"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2021-11-01T18:03", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211101/entities/gbq_results/article/article_308.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/77283"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/77283'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/77283'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/77283'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/77283'


 

This table displays all metadata directly associated to this object as RDF triples.

231 TRIPLES      22 PREDICATES      121 URIs      101 LITERALS      14 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/77283 schema:about N4715651ed0314f54809581b8abf43e27
2 N5413f3e113d040d384005d7d2cb09af0
3 N5577ac3e1d2c407f81f262ddfef2bd3d
4 N5b5f09c4953a4b1e8e0cffaf2bfa9ed1
5 N626d0e660c644ffbab049f5f6e7ee52b
6 N6f4672a5d7774a82b909a4b1c14fe867
7 Ndca231193a2749d3b9eced84703dfaf8
8 anzsrc-for:06
9 anzsrc-for:0601
10 anzsrc-for:10
11 anzsrc-for:1004
12 schema:author N60717ad5f7594726bd71b779d247b8c0
13 schema:citation sg:pub.10.1007/978-3-642-79496-4_8
14 sg:pub.10.1038/11320
15 sg:pub.10.1038/2057
16 sg:pub.10.1038/nm0697-639
17 sg:pub.10.1038/nm0995-890
18 sg:pub.10.1038/sj.cgt.7700001
19 sg:pub.10.1038/sj.cgt.7700104
20 sg:pub.10.1038/sj.gt.3300585
21 sg:pub.10.1038/sj.gt.3300910
22 sg:pub.10.1038/sj.onc.1203251
23 schema:datePublished 2000-07
24 schema:datePublishedReg 2000-07-01
25 schema:description Rapid advances are being made in the engineering of replication-competent viruses to treat cancer. Adenovirus is a mildly pathogenic human virus that propagates prolifically in epithelial cells, the origin of most human cancers. While virologists have revealed many details about its molecular interactions with the cell, applied scientists have developed powerful technologies to genetically modify or regulate every viral protein. In tandem, the limited success of nonreplicative adenoviral vectors in cancer gene therapy has brought the old concept of adenovirus oncolysis back into the spotlight. Major efforts have been directed toward achieving selective replication by the deletion of viral functions dispensable in tumor cells or by the regulation of viral genes with tumor-specific promoters. However, the predicted replication selectivity has not been realized because of incomplete knowledge of the complex virus–cell interactions and the leakiness of cellular promoters in the viral genome. Capsid modifications are being developed to achieve tumor targeting and enhance infectivity. Cellular and viral functions that confer greater oncolytic potency are also being elucidated. Ultimately, the interplay of the virus with the immune system will likely dictate the success of this approach as a cancer therapy.
26 schema:genre article
27 schema:inLanguage en
28 schema:isAccessibleForFree false
29 schema:isPartOf N386f46003faa474a98e947f2bd0b36b4
30 N8c7025588d8d44a7bc28fb8910e6c263
31 sg:journal.1115214
32 schema:keywords adenoviral vector
33 adenovirus
34 adenovirus oncolysis
35 advances
36 applied scientists
37 approach
38 cancer
39 cancer gene therapy
40 cancer therapy
41 capsid modification
42 cells
43 cellular promoters
44 complex virus-cell interactions
45 concept
46 deletion
47 detail
48 efforts
49 engineering
50 epithelial cells
51 function
52 gene therapy
53 genes
54 genome
55 greater oncolytic potency
56 human cancers
57 human viruses
58 immune system
59 incomplete knowledge
60 infectivity
61 interaction
62 interplay
63 knowledge
64 leakiness
65 limited success
66 major effort
67 modification
68 molecular interactions
69 most human cancers
70 nonreplicative adenoviral vectors
71 old concept
72 oncolysis
73 oncolytic potency
74 origin
75 pathogenic human viruses
76 potency
77 powerful technology
78 promoter
79 protein
80 rapid advances
81 regulation
82 replication
83 replication selectivity
84 replication-competent virus
85 replicative adenovirus
86 scientists
87 selective replication
88 selectivity
89 spotlight
90 success
91 system
92 tandem
93 targeting
94 technology
95 therapy
96 tumor cells
97 tumor targeting
98 tumor-specific promoters
99 vector
100 viral functions
101 viral genes
102 viral genome
103 viral proteins
104 virologists
105 virus
106 virus-cell interactions
107 schema:name Replicative adenoviruses for cancer therapy
108 schema:pagination 723-727
109 schema:productId N50267a15835b4d0eb517e69860a377db
110 Nd67e688ad51142648f4a34a79c2614c6
111 Ne7bfd893a1e04173946626a49a013f31
112 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020669485
113 https://doi.org/10.1038/77283
114 schema:sdDatePublished 2021-11-01T18:03
115 schema:sdLicense https://scigraph.springernature.com/explorer/license/
116 schema:sdPublisher N4f196543e70a43a681d47161fc4864e4
117 schema:url https://doi.org/10.1038/77283
118 sgo:license sg:explorer/license/
119 sgo:sdDataset articles
120 rdf:type schema:ScholarlyArticle
121 N386f46003faa474a98e947f2bd0b36b4 schema:volumeNumber 18
122 rdf:type schema:PublicationVolume
123 N4715651ed0314f54809581b8abf43e27 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Neoplasms
125 rdf:type schema:DefinedTerm
126 N4f196543e70a43a681d47161fc4864e4 schema:name Springer Nature - SN SciGraph project
127 rdf:type schema:Organization
128 N50267a15835b4d0eb517e69860a377db schema:name pubmed_id
129 schema:value 10888838
130 rdf:type schema:PropertyValue
131 N5413f3e113d040d384005d7d2cb09af0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Genetic Vectors
133 rdf:type schema:DefinedTerm
134 N5577ac3e1d2c407f81f262ddfef2bd3d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Models, Biological
136 rdf:type schema:DefinedTerm
137 N5b5f09c4953a4b1e8e0cffaf2bfa9ed1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Genetic Therapy
139 rdf:type schema:DefinedTerm
140 N60717ad5f7594726bd71b779d247b8c0 rdf:first sg:person.01210770006.56
141 rdf:rest Nccb9393fa26f4367864dc66299755af6
142 N626d0e660c644ffbab049f5f6e7ee52b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Humans
144 rdf:type schema:DefinedTerm
145 N6f4672a5d7774a82b909a4b1c14fe867 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Animals
147 rdf:type schema:DefinedTerm
148 N8c7025588d8d44a7bc28fb8910e6c263 schema:issueNumber 7
149 rdf:type schema:PublicationIssue
150 Nccb9393fa26f4367864dc66299755af6 rdf:first sg:person.0676575104.48
151 rdf:rest Nfaafa985c56549bdbb48904193d3f44e
152 Nd67e688ad51142648f4a34a79c2614c6 schema:name doi
153 schema:value 10.1038/77283
154 rdf:type schema:PropertyValue
155 Ndca231193a2749d3b9eced84703dfaf8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Adenoviridae
157 rdf:type schema:DefinedTerm
158 Ne7bfd893a1e04173946626a49a013f31 schema:name dimensions_id
159 schema:value pub.1020669485
160 rdf:type schema:PropertyValue
161 Nfaafa985c56549bdbb48904193d3f44e rdf:first sg:person.014245610777.23
162 rdf:rest rdf:nil
163 anzsrc-for:06 schema:inDefinedTermSet anzsrc-for:
164 schema:name Biological Sciences
165 rdf:type schema:DefinedTerm
166 anzsrc-for:0601 schema:inDefinedTermSet anzsrc-for:
167 schema:name Biochemistry and Cell Biology
168 rdf:type schema:DefinedTerm
169 anzsrc-for:10 schema:inDefinedTermSet anzsrc-for:
170 schema:name Technology
171 rdf:type schema:DefinedTerm
172 anzsrc-for:1004 schema:inDefinedTermSet anzsrc-for:
173 schema:name Medical Biotechnology
174 rdf:type schema:DefinedTerm
175 sg:grant.2474544 http://pending.schema.org/fundedItem sg:pub.10.1038/77283
176 rdf:type schema:MonetaryGrant
177 sg:grant.7145216 http://pending.schema.org/fundedItem sg:pub.10.1038/77283
178 rdf:type schema:MonetaryGrant
179 sg:journal.1115214 schema:issn 1087-0156
180 1546-1696
181 schema:name Nature Biotechnology
182 schema:publisher Springer Nature
183 rdf:type schema:Periodical
184 sg:person.01210770006.56 schema:affiliation grid-institutes:None
185 schema:familyName Alemany
186 schema:givenName Ramon
187 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01210770006.56
188 rdf:type schema:Person
189 sg:person.014245610777.23 schema:affiliation grid-institutes:None
190 schema:familyName Curiel
191 schema:givenName David T.
192 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014245610777.23
193 rdf:type schema:Person
194 sg:person.0676575104.48 schema:affiliation grid-institutes:None
195 schema:familyName Balagué
196 schema:givenName Cristina
197 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0676575104.48
198 rdf:type schema:Person
199 sg:pub.10.1007/978-3-642-79496-4_8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005567172
200 https://doi.org/10.1007/978-3-642-79496-4_8
201 rdf:type schema:CreativeWork
202 sg:pub.10.1038/11320 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023937493
203 https://doi.org/10.1038/11320
204 rdf:type schema:CreativeWork
205 sg:pub.10.1038/2057 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046761704
206 https://doi.org/10.1038/2057
207 rdf:type schema:CreativeWork
208 sg:pub.10.1038/nm0697-639 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021949192
209 https://doi.org/10.1038/nm0697-639
210 rdf:type schema:CreativeWork
211 sg:pub.10.1038/nm0995-890 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002841399
212 https://doi.org/10.1038/nm0995-890
213 rdf:type schema:CreativeWork
214 sg:pub.10.1038/sj.cgt.7700001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030233705
215 https://doi.org/10.1038/sj.cgt.7700001
216 rdf:type schema:CreativeWork
217 sg:pub.10.1038/sj.cgt.7700104 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027092476
218 https://doi.org/10.1038/sj.cgt.7700104
219 rdf:type schema:CreativeWork
220 sg:pub.10.1038/sj.gt.3300585 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031256245
221 https://doi.org/10.1038/sj.gt.3300585
222 rdf:type schema:CreativeWork
223 sg:pub.10.1038/sj.gt.3300910 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047885588
224 https://doi.org/10.1038/sj.gt.3300910
225 rdf:type schema:CreativeWork
226 sg:pub.10.1038/sj.onc.1203251 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008238922
227 https://doi.org/10.1038/sj.onc.1203251
228 rdf:type schema:CreativeWork
229 grid-institutes:None schema:alternateName Division of Human Gene Therapy, Departments of Medicine, Pathology, and Surgery, Gene Therapy Center, University of Alabama at Birmingham, AL 35294-3300, Birmingham
230 schema:name Division of Human Gene Therapy, Departments of Medicine, Pathology, and Surgery, Gene Therapy Center, University of Alabama at Birmingham, AL 35294-3300, Birmingham
231 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...